KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,458,113 | +32.8% | 659,569 | +7.7% | 0.00% | 0.0% |
Q2 2023 | $8,626,140 | +40.8% | 612,652 | +7.6% | 0.00% | 0.0% |
Q1 2023 | $6,125,980 | +75028.5% | 569,329 | +4.6% | 0.00% | 0.0% |
Q4 2022 | $8,154 | -99.9% | 544,337 | +4.0% | 0.00% | 0.0% |
Q3 2022 | $6,721,000 | +30.5% | 523,473 | -1.5% | 0.00% | 0.0% |
Q2 2022 | $5,149,000 | -0.2% | 531,469 | +2.3% | 0.00% | 0.0% |
Q1 2022 | $5,161,000 | -17.8% | 519,294 | -2.6% | 0.00% | 0.0% |
Q4 2021 | $6,275,000 | +15.6% | 533,217 | +11.9% | 0.00% | 0.0% |
Q3 2021 | $5,426,000 | -15.1% | 476,395 | +3.8% | 0.00% | 0.0% |
Q2 2021 | $6,391,000 | -18.4% | 458,859 | +8.5% | 0.00% | 0.0% |
Q1 2021 | $7,828,000 | +17.1% | 422,909 | +11.7% | 0.00% | 0.0% |
Q4 2020 | $6,687,000 | +25.8% | 378,482 | +9.1% | 0.00% | 0.0% |
Q3 2020 | $5,314,000 | -11.2% | 346,889 | +47.6% | 0.00% | 0.0% |
Q2 2020 | $5,987,000 | +89.5% | 234,986 | +15.1% | 0.00% | 0.0% |
Q1 2020 | $3,160,000 | -25.0% | 204,149 | -46.4% | 0.00% | – |
Q4 2019 | $4,214,000 | +198.7% | 381,036 | +129.7% | 0.00% | – |
Q3 2019 | $1,411,000 | -35.7% | 165,901 | +2.3% | 0.00% | -100.0% |
Q2 2019 | $2,194,000 | -19.0% | 162,109 | +8.0% | 0.00% | 0.0% |
Q1 2019 | $2,710,000 | -50.1% | 150,096 | -22.4% | 0.00% | 0.0% |
Q4 2018 | $5,434,000 | +119.5% | 193,502 | +99.2% | 0.00% | 0.0% |
Q3 2018 | $2,476,000 | – | 97,123 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |